RxDoctor Payments Data

Mark Morgan, MD

Plastic and Reconstructive Surgery · Wilmington, NCNPI 1275535072

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $14,374 of the $23,425 with a category attached, or 61.4%. AbbVie accounts for 96.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $8,405 and has fallen 73.1% since, to $2,263 in 2025.

$23,425in general payments, 2019–2025

Across 158 payments — averaging $148.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$22K
  • Motiva USA, LLC$573
  • RTI Surgical, Inc$124
  • Mentor Worldwide LLC$99
  • Johnson & Johnson$44
  • Polynovo North America LLC$25
  • plus $70 from 4 others
$10,306in research payments, 2019–2025

Across 4 payments — averaging $2576.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$10K

What the payments were for

  • Consulting fees$4,35019%
  • Speaking & faculty fees$14,37461%
  • Travel & lodging$7673%
  • Food & beverage$3,93417%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,425 in reported general payments places this provider in the 85th percentile of 55 plastic and reconstructive surgery providers in North Carolina.

See all plastic and reconstructive surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$105,397
Medicare patients
192
Services billed
489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin65$425
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen46$267
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen29$253
Promethazine Hcl39$134
Clindamycin Hcl20$118
Cyclobenzaprine Hcl18$96

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Wilmington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →